Skip to content

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Comparison Between the European and Japanese Pathological Investigation for Colon Cancer (SPACE)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06119867
Acronym
SPACE
Enrollment
430
Registered
2023-11-07
Start date
2023-11-14
Completion date
2027-12-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Neoplasms

Brief summary

In general, the European pathological examination method primarily relies on pathologists and does not require the involvement of surgeons. The Japanese pathological evaluation approach, on the other hand, involves the intervention of surgeons, particularly in the extraction of lymph nodes from fresh specimens and the assessment of specimen quality. Given that the Japanese pathological assessment method lacks systematic evaluation and there is currently no literature clearly demonstrating its diagnostic accuracy, the main objective of this study is to verify whether the diagnostic accuracy of the Japanese pathological investigation method is inferior to that of the European pathological evaluation method.

Interventions

PROCEDUREJapanese pathological investigation

Japanese pathological investigation

PROCEDUREEuropean pathological investigation

The European pathology evaluation method involves the analysis of fresh and intact specimens. Pathologists carefully inspect the entire specimen's appearance and assess the surgical resection plane and capture complete photographs for documentation purposes before further sectioning the specimen. During specimen processing, the CRM is initially marked with ink or other markers. After fixation, macroscopic data are recorded, and the entire length of the intestine is cut into cross-sections at intervals of 3-4 millimeters. These sections are then undergoing subsequent systematic pathological examination. However, the surgeon will be involved in the Japanese pathological investigation method. Intraoperative markings will be made 10 cm bilaterally from the primary tumor area. The resected colon will be incised at 1 cm intervals, after which the pericolic lymph nodes will be harvested. Each single retrieved lymph node will be packed up independently and will be examined by the pathologist.

Sponsors

Russian Society of Colorectal Surgeons
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with colon cancer who underwent colectomy; * Patients with pathological confirmed adenocarcinoma; * Patients agreed to participate in the study.

Exclusion criteria

* Patients suffered from rectal cancer; * Patients diagnosed with colon cancer but did not undergo colectomy; * Patients refused participation.

Design outcomes

Primary

MeasureTime frameDescription
Comparision of the incidence of stage III colon cancer between European and Japanese pathological investigation methods.up to 24 monthsindentification of the rate of postive lymph nodes

Secondary

MeasureTime frameDescription
The role of immunohistochemical examination in the Node (N) stage determinationup to 24 monthsindentification of the rate of postive lymph nodes using immunohistochemical examination
Comparison of the lymph node ratio (LNR) between the European and Japanese pathological approachesup to 24 monthsLNR=Postivie lymph node/ Total retrived lymph node
Comparison of the pT Stage between the European and Japanese pathological approachesup to 24 monthsindentification of the rate of the pathological T stages
Comparison of the resection margin (proximal, distal, circular) between the European and Japanese pathological approachesup to 24 monthsindentification of the rate of the postive proximal, distal or circular resection margin
Comparison of the tumor budding between the European and Japanese pathological approachesup to 24 monthsindentification of the rate of tumor budding
Comparison of the tumor-infiltrating lymphocytes (TIL) count between the European and Japanese pathological approachesup to 24 monthsindentification of the rate of the tumor-infiltrating lymphocytes (TIL) count
Comparison of the extracapsular invasion between the European and Japanese pathological approachesup to 24 monthsindentification of the rate of the extracapsular invasion
Comparison of the extramural invasion (venous, lymphatic, perineural) between the European and Japanese pathological approachesup to 24 monthsindentification of the rate of the venous, lymphatic or perineural extramural invasion

Countries

Russia

Contacts

CONTACTMingze He
hemingze97@gmail.com+79801881266
PRINCIPAL_INVESTIGATORVladimir Balaban

Sechenov University

STUDY_DIRECTORPetr Tsarkov

Sechenov University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026